vs
Encompass Health Corp（EHC）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是Rollins, Inc.的1.7倍（$1.5B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs 9.5%，领先2.4%），Rollins, Inc.同比增速更快（10.2% vs 9.9%），Encompass Health Corp自由现金流更多（$116.7M vs $111.2M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs 0.8%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
EHC vs ROL — 直观对比
营收规模更大
EHC
是对方的1.7倍
$906.4M
营收增速更快
ROL
高出0.3%
9.9%
净利率更高
ROL
高出2.4%
9.5%
自由现金流更多
EHC
多$5.5M
$111.2M
两年增速更快
EHC
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $906.4M |
| 净利润 | $146.1M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | 16.7% | 16.1% |
| 净利率 | 9.5% | 11.9% |
| 营收同比 | 9.9% | 10.2% |
| 净利润同比 | 20.8% | 2.5% |
| 每股收益（稀释后） | $1.43 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $999.5M | ||
| Q1 25 | $1.5B | $822.5M | ||
| Q4 24 | $1.4B | $832.2M | ||
| Q3 24 | $1.4B | $916.3M | ||
| Q2 24 | $1.3B | $891.9M |
净利润EHCROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $146.1M | $116.4M | ||
| Q3 25 | $126.5M | $163.5M | ||
| Q2 25 | $142.1M | $141.5M | ||
| Q1 25 | $151.5M | $105.2M | ||
| Q4 24 | $120.9M | $105.7M | ||
| Q3 24 | $108.2M | $136.9M | ||
| Q2 24 | $114.1M | $129.4M |
营业利润率EHCROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 16.7% | 17.5% | ||
| Q3 25 | 14.9% | 21.9% | ||
| Q2 25 | 16.2% | 19.8% | ||
| Q1 25 | 16.4% | 17.3% | ||
| Q4 24 | 14.3% | 18.1% | ||
| Q3 24 | 13.6% | 20.9% | ||
| Q2 24 | 14.3% | 20.4% |
净利率EHCROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 9.5% | 12.8% | ||
| Q3 25 | 8.6% | 15.9% | ||
| Q2 25 | 9.7% | 14.2% | ||
| Q1 25 | 10.4% | 12.8% | ||
| Q4 24 | 8.6% | 12.7% | ||
| Q3 24 | 8.0% | 14.9% | ||
| Q2 24 | 8.8% | 14.5% |
每股收益（稀释后）EHCROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $1.43 | $0.24 | ||
| Q3 25 | $1.24 | $0.34 | ||
| Q2 25 | $1.39 | $0.29 | ||
| Q1 25 | $1.48 | $0.22 | ||
| Q4 24 | $1.18 | $0.22 | ||
| Q3 24 | $1.06 | $0.28 | ||
| Q2 24 | $1.12 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $116.5M |
| 总债务越低越好 | $2.4B | $650.6M |
| 股东权益账面价值 | $2.4B | $1.4B |
| 总资产 | $7.1B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资EHCROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $72.2M | $100.0M | ||
| Q3 25 | $48.7M | $127.4M | ||
| Q2 25 | $99.1M | $123.0M | ||
| Q1 25 | $95.8M | $201.2M | ||
| Q4 24 | $85.4M | $89.6M | ||
| Q3 24 | $147.8M | $95.3M | ||
| Q2 24 | $154.4M | $106.7M |
总债务EHCROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $2.4B | $486.1M | ||
| Q3 25 | $2.4B | $485.7M | ||
| Q2 25 | $2.3B | $485.3M | ||
| Q1 25 | $2.3B | $485.5M | ||
| Q4 24 | $2.4B | $395.3M | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — |
股东权益EHCROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.4B | $1.4B | ||
| Q3 25 | $2.4B | $1.5B | ||
| Q2 25 | $2.3B | $1.4B | ||
| Q1 25 | $2.2B | $1.4B | ||
| Q4 24 | $2.1B | $1.3B | ||
| Q3 24 | $2.0B | $1.3B | ||
| Q2 24 | $1.8B | $1.2B |
总资产EHCROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $7.1B | $3.1B | ||
| Q3 25 | $6.9B | $3.2B | ||
| Q2 25 | $6.8B | $3.2B | ||
| Q1 25 | $6.6B | $2.9B | ||
| Q4 24 | $6.5B | $2.8B | ||
| Q3 24 | $6.5B | $2.8B | ||
| Q2 24 | $6.4B | $2.8B |
负债/权益比EHCROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 1.00× | 0.35× | ||
| Q3 25 | 1.01× | 0.32× | ||
| Q2 25 | 1.02× | 0.34× | ||
| Q1 25 | 1.08× | 0.36× | ||
| Q4 24 | 1.14× | 0.30× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $111.2M |
| 自由现金流率自由现金流/营收 | 7.6% | 12.3% |
| 资本支出强度资本支出/营收 | 14.8% | 0.8% |
| 现金转化率经营现金流/净利润 | 2.37× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $621.1M |
8季度趋势，按日历期对齐
经营现金流EHCROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $346.0M | $164.7M | ||
| Q3 25 | $270.8M | $191.3M | ||
| Q2 25 | $270.2M | $175.1M | ||
| Q1 25 | $288.6M | $146.9M | ||
| Q4 24 | $278.8M | $188.2M | ||
| Q3 24 | $267.8M | $146.9M | ||
| Q2 24 | $217.4M | $145.1M |
自由现金流EHCROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $116.7M | $159.0M | ||
| Q3 25 | $83.7M | $182.8M | ||
| Q2 25 | $113.3M | $168.0M | ||
| Q1 25 | $125.5M | $140.1M | ||
| Q4 24 | $80.1M | $184.0M | ||
| Q3 24 | $120.3M | $139.4M | ||
| Q2 24 | $60.5M | $136.4M |
自由现金流率EHCROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 7.6% | 17.4% | ||
| Q3 25 | 5.7% | 17.8% | ||
| Q2 25 | 7.8% | 16.8% | ||
| Q1 25 | 8.6% | 17.0% | ||
| Q4 24 | 5.7% | 22.1% | ||
| Q3 24 | 8.9% | 15.2% | ||
| Q2 24 | 4.6% | 15.3% |
资本支出强度EHCROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 14.8% | 0.6% | ||
| Q3 25 | 12.7% | 0.8% | ||
| Q2 25 | 10.8% | 0.7% | ||
| Q1 25 | 11.2% | 0.8% | ||
| Q4 24 | 14.1% | 0.5% | ||
| Q3 24 | 10.9% | 0.8% | ||
| Q2 24 | 12.1% | 1.0% |
现金转化率EHCROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 2.37× | 1.41× | ||
| Q3 25 | 2.14× | 1.17× | ||
| Q2 25 | 1.90× | 1.24× | ||
| Q1 25 | 1.90× | 1.40× | ||
| Q4 24 | 2.31× | 1.78× | ||
| Q3 24 | 2.48× | 1.07× | ||
| Q2 24 | 1.91× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
ROL
暂无分部数据
